Cargando…
Can mutations in ELA2, neutrophil elastase expression or differential cell toxicity explain sulphasalazine-induced agranulocytosis?
BACKGROUND: Drug-induced agranulocytosis, a severe side effect marked by a deficit or absolute lack of granulocytic white blood cells, is a rare side-effect of the anti-inflammatory drug sulphasalazine. Mutations in the human neutrophil elastase gene (ELA2), causing increased intracellular concentra...
Autores principales: | Jacobson, Annica, Melhus, Håkan, Wadelius, Mia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535939/ https://www.ncbi.nlm.nih.gov/pubmed/15575961 http://dx.doi.org/10.1186/1471-2326-4-5 |
Ejemplares similares
-
Adverse Reactions to Sulphasalazine
por: Hamilton, M., et al.
Publicado: (1987) -
Modulation of cisplatin cytotoxicity by sulphasalazine.
por: Awasthi, S., et al.
Publicado: (1994) -
Co-carcinogenic effect of sulphasalazine.
por: Meenan, J.
Publicado: (1993) -
Reversible Germ Cell Toxicity of Sulphasalazine and Ampicillin Combination in Male Rats
por: Gupta, Himanshu, et al.
Publicado: (2013) -
ELA AS DEPICTED IN BRHATRAYI
por: Nair, K. Vasudevan, et al.
Publicado: (1984)